促红细胞生成素受体。亚基结构与激活 - Suppr

Suppr

超能文献

Erythropoietin receptor. Subunit structure and activation.

作者信息

D'Andrea A D, Zon L I

机构信息

Children's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

出版信息

J Clin Invest. 1990 Sep;86(3):681-7. doi: 10.1172/JCI114763.

DOI:10.1172/JCI114763

PMID:2168441

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC296781/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a41/296781/0a9b88b726b2/jcinvest00075-0009-a.jpg

相似文献

Erythropoietin receptor. Subunit structure and activation.促红细胞生成素受体。亚基结构与激活

J Clin Invest. 1990 Sep;86(3):681-7. doi: 10.1172/JCI114763.

The role of erythropoietin in erythroid cell differentiation.促红细胞生成素在红系细胞分化中的作用。

Contrib Nephrol. 1988;66:25-37. doi: 10.1159/000416001.

Structure and function of the erythropoietin receptor in stable erythropoietin-dependent transfectants.稳定的促红细胞生成素依赖性转染细胞中促红细胞生成素受体的结构与功能

Contrib Nephrol. 1991;88:48-56; discussion 57-8.

Erythropoietin receptor mutations and Olympic glory.促红细胞生成素受体突变与奥运荣耀。

Nat Genet. 1993 Jun;4(2):108-10. doi: 10.1038/ng0693-108.

[Growth factors in erythropoiesis--physiologic function, structure and metabolism of erythropoietin].[红细胞生成中的生长因子——促红细胞生成素的生理功能、结构与代谢]

Tanpakushitsu Kakusan Koso. 1988 Oct;33(13):2345-56.

The mechanism of erythropoietin action.促红细胞生成素的作用机制。

Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):20-3.

Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family.促红细胞生成素受体与白细胞介素-2受体β链：一个新的受体家族。

Cell. 1989 Sep 22;58(6):1023-4. doi: 10.1016/0092-8674(89)90499-6.

The molecular physiology of erythropoietin and the erythropoietin receptor.促红细胞生成素与促红细胞生成素受体的分子生理学

Curr Opin Hematol. 1994 Mar;1(2):113-8.

Activation of the erythropoietin receptor in stable lymphoid and myeloid transfectants.稳定的淋巴样和髓样转染细胞中促红细胞生成素受体的激活。

Semin Hematol. 1991 Apr;28(2):152-7.

Erythropoietin: induction of synthesis to signal transduction.促红细胞生成素：从合成诱导到信号转导

J Mol Endocrinol. 1994 Apr;12(2):131-48. doi: 10.1677/jme.0.0120131.

引用本文的文献

Erythropoietin restrains the inhibitory potential of interneurons in the mouse hippocampus.促红细胞生成素抑制小鼠海马中的中间神经元的抑制潜能。

Mol Psychiatry. 2024 Oct;29(10):2979-2996. doi: 10.1038/s41380-024-02528-2. Epub 2024 Apr 15.

Isolation and evaluation of erythroid progenitors in the livers of larval, froglet, and adult Xenopus tropicalis.在非洲爪蟾（Xenopus tropicalis）的幼虫、蝌蚪和成体肝脏中分离和评估红系祖细胞。

Biol Open. 2023 Aug 15;12(8). doi: 10.1242/bio.059862. Epub 2023 Jul 27.

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection.第二代非造血性促红细胞生成素衍生肽的神经保护作用。

Redox Biol. 2022 Feb;49:102223. doi: 10.1016/j.redox.2021.102223. Epub 2021 Dec 21.

Erythropoietin Receptor Signaling and Lipid Rafts.促红细胞生成素受体信号转导与脂筏

Vitam Horm. 2017;105:79-100. doi: 10.1016/bs.vh.2017.02.002. Epub 2017 Mar 23.

Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation.AKT和ERK信号通路组分的蛋白质丰度决定细胞类型特异性的增殖调控。

Mol Syst Biol. 2017 Jan 24;13(1):904. doi: 10.15252/msb.20167258.

EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis.促红细胞生成素受体存在于小鼠C2C12细胞和人原代骨骼肌细胞中，但促红细胞生成素不影响肌生成。

Physiol Rep. 2014 Mar 27;2(3):e00256. doi: 10.1002/phy2.256. Print 2014.

Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.促红细胞生成素刺激剂的临床药代动力学和药效学。

Clin Pharmacokinet. 2013 Dec;52(12):1063-83. doi: 10.1007/s40262-013-0098-x.

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?促红细胞生成素（EPO）及其受体在骨骼肌中的作用和调节：我们究竟了解多少？

Front Physiol. 2013 Jul 15;4:176. doi: 10.3389/fphys.2013.00176. eCollection 2013.

Ligand-independent thrombopoietin mutant receptor requires cell surface localization for endogenous activity.非配体依赖性血小板生成素突变体受体的内源性活性需要细胞表面定位。

J Biol Chem. 2009 May 1;284(18):11781-91. doi: 10.1074/jbc.M808703200. Epub 2009 Mar 4.

Erythropoietin and oxidative stress.促红细胞生成素与氧化应激

Curr Neurovasc Res. 2008 May;5(2):125-42. doi: 10.2174/156720208784310231.

本文引用的文献

Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.具有白血病特征的疾病在成年瑞士小鼠中的无细胞传播。

J Exp Med. 1957 Apr 1;105(4):307-18. doi: 10.1084/jem.105.4.307.

Polycythemia: mechanisms and management.红细胞增多症：机制与管理

Ann Intern Med. 1981 Jul;95(1):71-87. doi: 10.7326/0003-4819-95-1-71.

Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro.引起红细胞增多症和贫血的红白血病病毒在体外表现出不同的红系转化作用。

Cell. 1980 Dec;22(3):693-9. doi: 10.1016/0092-8674(80)90545-0.

Stimulation of the adenylate cyclase activity of rabbit bone marrow immature erythroblasts by erythropoietin and haemin.促红细胞生成素和血红素对兔骨髓未成熟成红细胞腺苷酸环化酶活性的刺激作用。

Eur J Biochem. 1986 Mar 3;155(2):363-70. doi: 10.1111/j.1432-1033.1986.tb09499.x.

Isolation and characterization of genomic and cDNA clones of human erythropoietin.人促红细胞生成素基因组和cDNA克隆的分离与鉴定

Nature. 1985;313(6005):806-10. doi: 10.1038/313806a0.

Erythropoietin coming of age.促红细胞生成素走向成熟。

N Engl J Med. 1987 Jan 8;316(2):101-3. doi: 10.1056/NEJM198701083160207.

Binding and internalization of recombinant human erythropoietin in murine erythroid precursor cells.重组人促红细胞生成素在小鼠红系前体细胞中的结合与内化

Blood. 1987 May;69(5):1485-90.

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.用重组人促红细胞生成素纠正终末期肾病贫血。一项I期和II期联合临床试验的结果。

N Engl J Med. 1987 Jan 8;316(2):73-8. doi: 10.1056/NEJM198701083160203.

Erythropoietin rapidly alters phosphorylation of pp43, an erythroid membrane protein.促红细胞生成素能迅速改变一种红细胞膜蛋白pp43的磷酸化状态。

J Biol Chem. 1987 Mar 5;262(7):2933-6.

Murine erythroleukaemia cells (Friend cells) possess high-affinity binding sites for erythropoietin.小鼠红白血病细胞（弗瑞德细胞）拥有促红细胞生成素的高亲和力结合位点。

FEBS Lett. 1987 Jan 26;211(2):229-33. doi: 10.1016/0014-5793(87)81442-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验